These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection]. Ren ZG; Gan YH; Fan J; Chen Y; Wu ZQ; Qin LX; Ge NL; Zhou J; Xia JL; Wang YH; Ye QH; Wang L; Ye SL Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1614-6. PubMed ID: 19094752 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Ibrahim S; Roychowdhury A; Hean TK Am J Surg; 2007 Jul; 194(1):17-22. PubMed ID: 17560903 [TBL] [Abstract][Full Text] [Related]
4. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357 [TBL] [Abstract][Full Text] [Related]
5. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723 [TBL] [Abstract][Full Text] [Related]
7. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation]. Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186 [TBL] [Abstract][Full Text] [Related]
9. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Kim YS; Rhim H; Cho OK; Koh BH; Kim Y Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240 [TBL] [Abstract][Full Text] [Related]
10. Low P2/MS value is an independent risk factor for early recurrence of hepatocellular carcinoma after radiofrequency ablation therapy. Kwak MS; Lee JH; Chung GE; Yu SJ; Jung EU; Kim BH; Choi DH; Kim HY; Kim SH; Lee JM; Lee JY; Kim YJ; Yoon JH; Lee HS Hepatogastroenterology; 2011; 58(105):147-52. PubMed ID: 21510303 [TBL] [Abstract][Full Text] [Related]
11. Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma. Fujita T J Hepatol; 2009 May; 50(5):1051-2; author reply 1052-3. PubMed ID: 19329216 [No Abstract] [Full Text] [Related]
12. Carbon dioxide-enhanced sonographically guided radiofrequency ablation combined with transcatheter arterial chemoembolization for sonographically undetectable hepatocellular carcinoma. Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S Hepatogastroenterology; 2005; 52(65):1344-6. PubMed ID: 16201070 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy (Br J Surg 2002; 89: 752-6). Rai R; Seymour K; Manas D Br J Surg; 2002 Dec; 89(12):1620. PubMed ID: 12445077 [No Abstract] [Full Text] [Related]
15. Diabetes mellitus and prognosis after curative therapy for hepatocellular carcinoma: alas, still grave for those who are hyperglycemic. Teoh NC; Fan JG J Gastroenterol Hepatol; 2008 Nov; 23(11):1633-4. PubMed ID: 19120856 [No Abstract] [Full Text] [Related]
16. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Goldberg SN; Solbiati L Hepatology; 2001 Sep; 34(3):609; author reply 610-1. PubMed ID: 11526553 [No Abstract] [Full Text] [Related]
17. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Livraghi T Hepatology; 2001 Sep; 34(3):608-9; author reply 610-1. PubMed ID: 11526552 [No Abstract] [Full Text] [Related]